Citrate level in osteoporotic women treated with estrogen and alendronate

被引：0
|
作者：
D'Amelio, P
Beccattini, W
Pescarmona, GP
Isaia, GC
机构：
[1] Univ Turin, Dept Gen Biol & Biochem, I-10124 Turin, Italy
[2] Univ Turin, Dept Internal Med, I-10124 Turin, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
374
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [1] Effects of combined estrogen and alendronate treatments in osteoporotic women
    Manno, R
    Caplan, F
    Christmas, C
    Bellantoni, M
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S43 - S43
  • [2] ATRIAL FIBRILLATION IN OSTEOPOROTIC WOMEN TREATED WITH ALENDRONATE
    Chang, L. C.
    Kao, Y. H.
    Hsiao, F. Y.
    Tsai, Y. W.
    Huang, W. F.
    VALUE IN HEALTH, 2011, 14 (03) : A123 - A123
  • [3] DENOSUMAB COMPARED WITH ALENDRONATE IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH ALENDRONATE
    Bernad, M.
    Garces, M.
    Martin Mola, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 768 - 768
  • [4] Quality of life in osteoporotic Turkish women treated with alendronate
    Akyüz, G
    Eskiyurt, N
    Ofluoglu, D
    Aki, S
    Kayhan, O
    Oncel, A
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S170 - S170
  • [5] Femoral strength in osteoporotic women treated with teriparatide or alendronate
    Keaveny, Tony M.
    McClung, Michael R.
    Wan, Xiaohai
    Kopperdahl, David L.
    Mitlak, Bruce H.
    Krohn, Kelly
    BONE, 2012, 50 (01) : 165 - 170
  • [6] Response to alendronate in osteoporotic women previously treated with pamidronate
    Peretz, A
    Siderova, V
    Body, JJ
    Dumon, JC
    Rozenberg, S
    Fellemans, C
    Fuss, M
    Bergmann, P
    MATURITAS, 2003, 44 (02) : 111 - 115
  • [7] Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate
    Sebastian-Ochoa, Arantzazu
    Fernandez-Garcia, Diego
    Reyes-Garcia, Rebeca
    Mezquita-Raya, Pedro
    Rozas-Moreno, Pedro
    Alonso-Garcia, Guillermo
    Munoz-Torres, Manuel
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (02): : 172 - 177
  • [8] EVALUATION OF THREE REGIMENS OF CHOLECALCIFEROL DOSING IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN TREATED WITH ALENDRONATE
    Kocjan, Tomaz
    Jensterle, Mojca
    Pfeifer, Marija
    Sabati Rajic, Antonela
    Bajuk Studen, Katica
    Prezelj, Janez
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S286 - S287
  • [9] Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy
    Palomba, S
    Orio, F
    Russo, T
    Colao, A
    Lombardi, G
    Zullo, F
    FERTILITY AND STERILITY, 2004, 81 (02) : 476 - 478
  • [10] The response of postmenopausal osteoporotic women to alendronate.
    Fairney, A
    Kyd, P
    Kerkhoff, F
    Murphy, M
    Thomas, E
    Wilson, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S467 - S467
12345